On Tuesday, Patterson-UTI Energy, Inc. (NASDAQ:PTEN)’s shares inclined 0.19% to $18.82.
Patterson-UTI Energy, Inc. (PTEN) declared that its May 2015 drill rig count averaged at 123–122 rigs in the U.S. and 1 in Canada. This marks a steep decline from 133 rigs operational in April.
Patterson-UTI further added that for the two months ending May 31, its rig count averaged 126 in the U.S. and 2 in Canada.
The weak crude pricing environment has forced most drillers to cut back on the number of rigs. Also, fewer new contracts and declining day rates have made maintaining profitability a challenge. Retiring rigs is therefore an effective way to curb operating expenses.
Moreover, Patterson-UTI has been undertaking other measures like lowering capital spending to tackle the pricing woes. The company has declared a 29% cut in its 2015 spending.
Patterson-UTI is a major onshore contract driller in the U.S. with over 239 land-based rigs that operate primarily in the oil and natural gas producing regions of North America.
Patterson-UTI Energy, Inc., through its auxiliaries, provides onshore contract drilling services to major and independent oil and natural gas operators in the United States and Canada. The company operates through three segments: Contract Drilling, Pressure Pumping, and Oil and Natural Gas.
QEP Resources Inc (NYSE:QEP)’s shares gained 0.65% to $18.51.
Baxalta Inc. will replace QEP Resources Inc. in the benchmark S&P 500 index, S&P Dow Jones Indices said.
That’s one of several changes the company declared to the S&P MidCap 400, S&P SmallCap 600 and the S&P 100 indices Friday.
Baxalta, a biopharmaceutical company based in Deerfield, Illinois, will join the index after the close of trading June 30. QEP, an oil and gas company, is being replaced because it’s near the bottom of the index, the company said.
Priceline Group Inc. will replace Baxter International Inc. in the S&P 100. Baxter, which is spinning off Baxalta later this month, will remain in the S&P 500.
QEP Resources, Inc., through its auxiliaries, operates as an exploration and production company. The company acquires, explores, develops, and produces natural gas, oil, and natural gas liquids (NGLs) primarily in the Pinedale Anticline in western Wyoming; the Williston Basin in North Dakota; the Uinta Basin in eastern Utah; the Permian Basin in western Texas; the Haynesville/Cotton Valley in northwestern Louisiana; and other proven properties in Wyoming, Utah, and Colorado.
At the end of Tuesday’s trade, Organovo Holdings Inc (NYSEMKT:ONVO)‘s shares surged 3.29% to $3.77.
Organovo Holdings Inc (ONVO) stated its financial results for the fiscal year ended March 31, 2015. The Company also stated its total contract bookings for the exVive3D™ Human Liver Tissue.
The exVive3D Human Liver Tissue is a combination product and service offered by the Company to pharmaceutical industry customers for use mainly in preclinical safety testing. From April 1, 2014 through the date of this release, the Company has recorded total contract bookings for its commercial liver tissue product of about $1.94 million, which comprises $0.29 million in revenue recognized as of March 31, 2015. The customers who have contracted to utilize the exVive3D Human Liver Tissue comprise multiple top 25 global pharma companies, additional public pharmaceutical companies from small to large cap and private venture-backed companies. The Company has had multiple customers sign a second contract, representing repeat business for its liver tissue product. The Company has signed liver service contracts with customers in the United States, Europe and Asia. These stated total contract bookings do not comprise the Company’s contract bookings associated with its research and development activities not involving the exVive3D Human Liver Tissue.
Organovo Holdings, Inc., a development-stage company, focuses on developing and commercializing functional human tissues that could be employed in drug discovery and development, biological research, and as therapeutic implants for the treatment of damaged or degenerating tissues and organs.
AerCap Holdings N.V. (NYSE:AER), ended its Tuesday’s trading session with -0.43% loss, and closed at $45.79.
AerCap Holdings N.V (AER) declared the completion of the secondary public offering of 71,184,686 of its ordinary shares by American International Group, Inc. (the “Selling Shareholder”) at a price to the public of $49.00 per ordinary share. In connection with the underwritten offering, the Selling Shareholder also granted the underwriters a 30-day option to purchase up to an additional 10,677,702 ordinary shares. AerCap will not receive any proceeds from the sale of the ordinary shares. AerCap also accomplished its formerly declared repurchase of 15,698,588 of its ordinary shares from the Selling Shareholder for $750 million.
Citigroup and Goldman, Sachs & Co. are serving as global coordinators and joint book running managers, and J.P. Morgan, Morgan Stanley & Co. LLC and UBS Investment Bank are serving as joint book running managers for the underwritten offering.
The Company has filed a registration statement (counting a prospectus) on Form F-3 with the SEC for the underwritten offering to which this communication relates. The registration statement automatically became effective upon filing on March 31, 2015. Investors should read the accompanying prospectus dated March 31, 2015, the prospectus supplement regarding the offering dated June 3, 2015 and other documents the Company has filed with the SEC for more complete information about the Company and this offering. These documents may be obtained for free by visiting EDGAR on the SEC`s website at www.sec.gov.
AerCap Holdings N.V., an independent aircraft leasing company, engages in the leasing, financing, sale, and administration of commercial aircraft and engines. The company provides aircraft asset administration and corporate services, counting remarketing aircraft; collecting rental and maintenance payments, monitoring aircraft maintenance, monitoring and enforcing contract compliance, and accepting delivery and redelivery of aircraft; and conducting ongoing lessee financial performance reviews. Its aircraft asset administration services also comprise periodically inspecting the leased aircraft; coordinating technical modifications to aircraft to meet new lessee requirements; conducting restructurings negotiations in connection with lease defaults; repossessing aircraft; arranging and monitoring insurance coverage; registering and de-registering aircraft; arranging for aircraft and aircraft engine valuations; and providing market research services.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should might occur.
